My IDSA Contact Us
IDSA NewsPrint-Friendly Newsletter
Forward to a Friend
Search Back Issues
Education & Training Resources Practice Guidelines Journals & Publications Policy & Advocacy Meetings About IDSA
September 2011
Top Stories
IDSA, PIDS Release Guidelines for Treating CAP in Children

The first national guidelines for the management of community-acquired pneumonia (CAP) in infants and children are now available. Developed by IDSA and the Pediatric Infectious Diseases Society, the guidelines are online and appear in the Oct. 1 issue of Clinical Infectious Diseases.

The guidelines are designed to provide physicians who care for children with a roadmap to the most scientifically valid diagnosis and treatment recommendations. They also place an emphasis on preventing bacterial pneumonia through immunization, including annual influenza vaccination for children 6 months and older, and for parents and caregivers of infants 6 months and younger.

Topics in the guidelines include:

  • site-of-care management decisions
  • diagnostic testing
  • anti-infective treatment
  • adjunctive surgical and non-anti-infective therapy
  • management of children not responding to treatment
  • discharge criteria
  • prevention

“Diagnostic methods and treatments that work well in adults may be too risky and not have the desired result in children,” said John S. Bradley, MD, FIDSA, lead author of the guidelines and professor and chief of the division of infectious diseases at the University of California at San Diego Department of Pediatrics. “With these guidelines, we are hopeful that the standard and quality of care children receive for community-acquired pneumonia will be consistent from doctor to doctor—providing much better treatment outcomes.”

For each of the guidelines’ specific recommendations, the strength of each as well as the quality of evidence for each is noted. The document also notes the lack of solid evidence in some areas, often due to the ethical challenges of studying children, and calls for research in specific areas.

The guidelines have been endorsed by the American Academy of Pediatrics, the American College of Emergency Physicians, the American Society of Microbiology, the American Thoracic Society, the Society for Hospital Medicine, and the Society of Critical Care Medicine.

The CAP guidelines are available online and are also being developed in both mobile device and pocketcard format for use at the point of care. Other IDSA guidelines are also available on the IDSA website, including guidelines available in these formats.
How useful is this article?

< Previous Article | Next Article >

Post a comment

Your name:

Your comment:

Patient Care and Science
CDC Makes New Recommendations for Influenza Immunization
EIN Update: CBC Monitoring for ID-Related Diseases
Drug Approvals, Recalls, Adverse Events Update
Global ID
Armed with Research on Early HIV Treatment, HIVMA and Global Center Make Case for More Funding
Congressional Staff Tours U.S.-funded HIV and TB programs in Kenya with Global Center
Science Speaks Interviews Key PEPFAR Staff
Policy and Advocacy
Policy Conference Addresses Lack of New Antibiotics
FDA Rolls Out New Foodborne Illness Response Network
Input Due Oct. 26 on Changes to Rules Protecting Human Research Subjects
IDSA Urges Fix to Flawed Medicare Physician Payment Formula
Your Colleagues
IDSA Congratulates the 2011 Joint Research Award Winners
Congratulations to the 2011 Medical Scholars Program Recipients
In Memoriam: Richard B. Hornick, MD, FIDSA (1929-2011)
Members on the Move
Welcome, New Members!
Education & Resources
New Toolkit Aims to Increase Pneumococcal Immunization in Adults
HIVMA Minority Clinical Fellowship Program: December 9 Application Deadline
Top Stories
From the President: A Year in Review
IDSA, PIDS Release Guidelines for Treating CAP in Children
Quick Guide to the New IDSA Website
IDSA Journal Club
IDSA | 1300 Wilson Blvd., Suite 300 | Arlington, VA 22209 | Phone: (703) 299-0200
To ensure delivery, please add '' to your email address book or Safe Sender List.
If you are still having problems receiving our communications,
see our white-listing page for more details.